The latest medical news on transthyretin amyloidosis
Online version
ATTR Expert
Thursday January 15, 2026
ATTR Expert
Hello     ,
Below, you will find the latest scientific news regarding transthyretin amyloidosis, sourced from the most prestigious peer-reviewed journals.
News

Amyloidosis of the heart: pathophysiology, diagnosis, and treatment
Expert Opinion on Pharmacotherapy 2025; 26(6): 731-41 |  Andy Wang et al.
Cardiac amyloidosis is characterized by amyloid fibril aggregation due to misfolded circulating proteins and their deposition in the heart, leading to cardiac damage and dysfunction. Given cardiac amyloidosis...
READ MORE +

Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm
Cardio-Oncology 2024; 10(1): 78 |  Ammon Jessica et al.
Amyloidosis is a disease characterized by extracellular tissue deposition of insoluble fibrils composed of abnormally folded proteins. Two types of amyloidosis are responsible for 95% of cardiac amyloidosis...
READ MORE +

Comparison of in-clinic assessment of 6MWT by conventional method and using wearable sensors for patients with ATTR-CM
Future Cardiology 2025; 21(2): 75-81 |  Prem Soman et al.
The 6-minute walk test (6MWT) is used to assess submaximal exercise capacity in clinical trials. Conducting the 6MWT can be challenging when patients cannot visit the clinic due to physical/travel limitations....
READ MORE +
Bibliographic data :  News  |  Archives  |  Highlight  |  My bibliography
Useful links:  Homepage  |  Bibliographic research
GNM Healthcare
Copyright 2026 © GNM Healthcare Consulting France SAS
With the institutional support of Alnylam Pharmaceuticals
Inform/Invite a colleague  | My account  | Delete my data
By requesting access to the "ATTR Expert" service, I agree that GNM Healthcare Consulting France SAS may use the data acquired during my access request to provide me with twice per month information related to its services in accordance with the Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to dpo@gnmhealthcare.com. You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.